BioSpace News Archive

Nutraceutical Corporation is pleased to announce that Dr. Raphael Kellman, MD will be advising the company in the development and promotion of its Solaray® Mycrobiome® Probiotic line of products.

Healogics Specialty Physician Care Continuum Program will increase the consistency, quality and speed of patient care through dedicated, focused physician leadership and clinical processes

The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares payable October 26, 2018 to shareholders of record on October 12, 2018.

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical needs, today announced that it has treated the first patient in its Phase IIb dose-confirmation study of AMT-061, an investigational AAV5-based gene therapy incorporating the FIX-Padua variant for the treatment of patients with severe and moderately severe hemophilia B.

Hill-Rom Holdings, Inc. (NYSE: HRC), today announced that it will present at the 16th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 13, 2018, in New York.

Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at three upcoming investor conferences.

Array BioPharma, Inc. Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Wells Fargo Securities 2018 Healthcare Conference in Boston.

MEI Pharma, Inc., (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year ended June 30, 2018.

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will participate in the following investor conferences: The

Illumina, Inc. today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast.